Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Increased Body Weight and Fat Mass After Subchronic GIP Receptor Antagonist, but Not GLP-2 Receptor Antagonist, Administration in Rats
Sara Baldassano, Lærke S. Gasbjerg, Hüsün Sheyma Kizilkaya, et al.
Frontiers in Endocrinology (2019) Vol. 10
Open Access | Times Cited: 28

Showing 1-25 of 28 citing articles:

Atypical Antipsychotics and Metabolic Syndrome: From Molecular Mechanisms to Clinical Differences
Marco Carli, Shivakumar Kolachalam, Biancamaria Longoni, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 3, pp. 238-238
Open Access | Times Cited: 163
Recent Advances in Incretin-Based Pharmacotherapies for the Treatment of Obesity and Diabetes
Qiming Tan, Seun Akindehin, Camila E. Orsso, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 105
Targeting the GIPR for obesity: To agonize or antagonize? Potential mechanisms
Jonathan E. Campbell
Molecular Metabolism (2020) Vol. 46, pp. 101139-101139
Open Access | Times Cited: 86
The Impact of Diet and Physical Activity on Bone Health in Children and Adolescents
Patrizia Proia, Alessandra Amato, Patrik Drid, et al.
Frontiers in Endocrinology (2021) Vol. 12
Open Access | Times Cited: 80
GIP and GLP-2 together improve bone turnover in humans supporting GIPR-GLP-2R co-agonists as future osteoporosis treatment
M Gabe, Kirsa Skov‐Jeppesen, Lærke S. Gasbjerg, et al.
Pharmacological Research (2022) Vol. 176, pp. 106058-106058
Closed Access | Times Cited: 33
Effects of a Resistance Training Protocol on Physical Performance, Body Composition, Bone Metabolism, and Systemic Homeostasis in Patients Diagnosed with Parkinson’s Disease: A Pilot Study
Alessandra Amato, Sara Baldassano, Sonya Vasto, et al.
International Journal of Environmental Research and Public Health (2022) Vol. 19, Iss. 20, pp. 13022-13022
Open Access | Times Cited: 23
GIP and the gut-bone axis – Physiological, pathophysiological and potential therapeutic implications
Signe Stensen, Lærke S. Gasbjerg, Mads M. Helsted, et al.
Peptides (2019) Vol. 125, pp. 170197-170197
Closed Access | Times Cited: 36
The Role of Consumption of Molybdenum Biofortified Crops in Bone Homeostasis and Healthy Aging
Sonya Vasto, Davide Baldassano, Leo Sabatino, et al.
Nutrients (2023) Vol. 15, Iss. 4, pp. 1022-1022
Open Access | Times Cited: 13
Effect of gut hormones on bone metabolism and their possible mechanisms in the treatment of osteoporosis
Hongyu Liu, Huimin Xiao, Sufen Lin, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 4
Consumption of lettuce with seaweed extract biostimulant application improved iron homeostasis in a randomized interventional trial of healthy individuals
Francesca Di Gaudio, Sonya Vasto, Leo Sabatino, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Glucagon-like Peptide-2 Acts Partially Through Central GLP-2R and MC4R in Mobilizing Stored Lipids from the Intestine
Kundanika Mukherjee, Muhammad Asaf Khan, John G. Howland, et al.
Nutrients (2025) Vol. 17, Iss. 9, pp. 1416-1416
Open Access
Analysis of Body Perception, Preworkout Meal Habits and Bone Resorption in Child Gymnasts
Alessandra Amato, Patrizia Proia, G Caldara, et al.
International Journal of Environmental Research and Public Health (2021) Vol. 18, Iss. 4, pp. 2184-2184
Open Access | Times Cited: 19
Nephroprotective Properties of the Glucose-Dependent Insulinotropic Polypeptide (GIP) and Glucagon-like Peptide-1 (GLP-1) Receptor Agonists
Tomislav Bulum
Biomedicines (2022) Vol. 10, Iss. 10, pp. 2586-2586
Open Access | Times Cited: 13
Is the Secret in the Gut? SuperJump Activity Improves Bone Remodeling and Glucose Homeostasis by GLP-1 and GIP Peptides in Eumenorrheic Women
Sonya Vasto, Alessandra Amato, Patrizia Proia, et al.
Biology (2022) Vol. 11, Iss. 2, pp. 296-296
Open Access | Times Cited: 12
Impact on Glucose Homeostasis: Is Food Biofortified with Molybdenum a Workable Solution? A Two-Arm Study
Sonya Vasto, Francesca Di Gaudio, Maria Raso, et al.
Nutrients (2022) Vol. 14, Iss. 7, pp. 1351-1351
Open Access | Times Cited: 12
A New Potential Dietary Approach to Supply Micronutrients to Physically Active People through Consumption of Biofortified Vegetables
Sara Baldassano, Maria Rita Polizzi, Leo Sabatino, et al.
Nutrients (2022) Vol. 14, Iss. 14, pp. 2971-2971
Open Access | Times Cited: 11
Chronic peptide-based GIP receptor inhibition exhibits modest glucose metabolic changes in mice when administered either alone or combined with GLP-1 agonism
Jason A. West, Anastasia Tsakmaki, Soumitra S. Ghosh, et al.
PLoS ONE (2021) Vol. 16, Iss. 3, pp. e0249239-e0249239
Open Access | Times Cited: 14
GIP(3-30)NH2 – a tool for the study of GIP physiology
Mads Bank Lynggaard, Lærke S. Gasbjerg, Mikkel Christensen, et al.
Current Opinion in Pharmacology (2020) Vol. 55, pp. 31-40
Closed Access | Times Cited: 11
N‐terminal alterations turn the gut hormone GLP‐2 into an antagonist with gradual loss of GLP‐2 receptor selectivity towards more GLP‐1 receptor interaction
M Gabe, Lærke S. Gasbjerg, Sarina Gadgaard, et al.
British Journal of Pharmacology (2022) Vol. 179, Iss. 18, pp. 4473-4485
Open Access | Times Cited: 7
Insights into the structure and activation mechanism of some class B1 GPCR family members
Hayrunisa Aksu, Ayşenur Demirbilek, Abdullahi İbrahim Uba
Molecular Biology Reports (2024) Vol. 51, Iss. 1
Closed Access | Times Cited: 1
Individual and combined effects of GIP and xenin on differentiation, glucose uptake and lipolysis in 3T3-L1 adipocytes
Andrew English, Sarah Craig, Peter R. Flatt, et al.
Biological Chemistry (2020) Vol. 401, Iss. 11, pp. 1293-1303
Open Access | Times Cited: 10
GIP Receptor Antagonist, SKL-14959 Indicated Alteration of the Lipids Metabolism to Catabolism by the Inhibition of Plasma LPL Activity, Resulting in the Suppression of Weight Gain on Diets-Induced Obesity Mice
Takashi Nakamura, Hitomi Tanimoto, Masayuki Okamoto, et al.
Diabetes Metabolic Syndrome and Obesity (2021) Vol. Volume 14, pp. 1095-1105
Open Access | Times Cited: 9
Boosting plant food polyphenol concentration by saline eustress as supplement strategies for the prevention of metabolic syndrome: an example of randomized interventional trial in the adult population
Vincenzo Ferrantelli, Sonya Vasto, Angelina Alongi, et al.
Frontiers in Nutrition (2023) Vol. 10
Open Access | Times Cited: 3
Distinct Identity of GLP-1R, GLP-2R, and GIPR Expressing Cells and Signaling Circuits Within the Gastrointestinal Tract
Nadya M. Morrow, Antonio A. Hanson, Erin E. Mulvihill
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 7
Advances in the Management of Diabetes and Overweight using Incretin-based Pharmacotherapies
Shatrudhan Prajapati
Current Diabetes Reviews (2023) Vol. 20, Iss. 7
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top